18 November 2017
News and Views
Links and Services
A study in the latest issue of Hepatology evaluates the effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease.
There is no licensed treatment for nonalcoholic fatty liver disease (NAFLD), a condition that inc
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors